Global Pathology Ltd 09808296 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is specialist medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 09808296 2024-04-01 2025-03-31 09808296 2025-03-31 09808296 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09808296 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 09808296 bus:Micro-entities 2024-04-01 2025-03-31 09808296 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09808296 bus:FilletedAccounts 2024-04-01 2025-03-31 09808296 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09808296 bus:RegisteredOffice 2024-04-01 2025-03-31 09808296 bus:Director1 2024-04-01 2025-03-31 09808296 bus:Director2 2024-04-01 2025-03-31 09808296 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09808296 countries:EnglandWales 2024-04-01 2025-03-31 09808296 2023-04-01 2024-03-31 09808296 2024-03-31 09808296 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 09808296 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 09808296

Global Pathology Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Global Pathology Ltd

Contents

Company Information

1

Directors' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

3

 

Global Pathology Ltd

Company Information

Directors

M Howard

O Wise

Registered office

Anglo House
Worcester Road
Stourport on Severn
DY13 9AW

 

Global Pathology Ltd

Directors' Report for the Year Ended 31 March 2025

The directors present their report and the financial statements for the year ended 31 March 2025.

This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Directors of the company

The directors who held office during the year were as follows:

M Howard

O Wise

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 8 December 2025 and signed on its behalf by:
 

.........................................
M Howard
Director

.........................................
O Wise
Director

 

Global Pathology Ltd

(Registration number: 09808296)
Balance Sheet as at 31 March 2025

2025
£

2024
£

Fixed assets

1,443

2,005

Current assets

144,553

236,472

Creditors: Amounts falling due within one year

(30,951)

(26,723)

Net current assets

113,602

209,749

Total assets less current liabilities

115,045

211,754

Creditors: Amounts falling due after more than one year

(1,120)

(1,600)

Accruals and deferred income

(2,232)

(996)

 

111,693

209,158

Capital and reserves

111,693

209,158

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Anglo House
Worcester Road
Stourport on Severn
DY13 9AW

These financial statements were authorised for issue by the Board on 8 December 2025.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 8 December 2025 and signed on its behalf by:
 

 

Global Pathology Ltd

(Registration number: 09808296)
Balance Sheet as at 31 March 2025

.........................................
M Howard
Director

.........................................
O Wise
Director